LYEL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $9.26

Market Cap (MRQ) $217M

P/E (TTM) -0.6

EPS (TTM) $-16.01

Revenue (TTM) $27.0K

ROE (TTM) -93.3%

52W Range $9–$40

LYEL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1

Ex-date	Split	Type
June 2, 2025	1-for-20	Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$36.0K

2019-12-31 → 2025-12-31

EPS$-16.06

2019-12-31 → 2025-12-31

Free Cash Flow$-151M

2021-12-31 → 2025-12-31

Net margin-920285.2%

2021-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	LYEL	5Y avg	Peer Median	Verdict
P/E (TTM)	-0.65Y avg ≈-36.5	≈-36.5	·	·
P/S (TTM)	8024.35Y avg ≈31914.9	≈31914.9	14.6	Overvalued
P/B (MRQ)	0.95Y avg ≈17.7	≈17.7	2.9	Undervalued
Price / FCF (TTM)	-1.65Y avg ≈-74.4	≈-74.4	·	·
Price / Cash Flow (TTM)	-1.65Y avg ≈-97.5	≈-97.5	·	·
Price / Tangible Book	0.95Y avg ≈17.7	≈17.7	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	LYEL	5Y avg	Peer Median	Verdict
Operating Margin (TTM)	-949981.5%5Y avg ≈-305742.2%	≈-305742.2%	-752.1%	Weak
EBITDA Margin (TTM)	-914733.3%5Y avg ≈-289750.0%	≈-289750.0%	-752.1%	Weak
Net Profit Margin (TTM)	-920285.2%5Y avg ≈-301538.5%	≈-301538.5%	-1884.8%	Weak
ROA (TTM)	-71.3%5Y avg ≈-38.3%	≈-38.3%	-27.3%	Weak
ROE (TTM)	-93.3%5Y avg ≈-51.7%	≈-51.7%	-31.2%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	5Y trend	LYEL	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)		5.45Y avg ≈11.9	≈11.9	8.4	Low liquidity
Quick Ratio		5.05Y avg ≈11.6	≈11.6	5.3	In line

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	LYEL	5Y avg	Peer Median	Verdict
Revenue YoY	-41.0%5Y avg ≈107.7%	≈107.7%	·	·
Revenue CAGR 3Y	-92.5%5Y avg ≈-83.0%	≈-83.0%	·	·
Revenue CAGR 5Y	-65.8%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	LYEL	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-16.065Y avg ≈$-12.71	≈$-12.71	·	·
Revenue / Share	$0.005Y avg ≈$15.74	≈$15.74	·	·
Cash Flow / Share	$-8.785Y avg ≈$-187.92	≈$-187.92	·	·
Cash / Share	$2.835Y avg ≈$1.09	≈$1.09	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	5Y trend	LYEL	5Y avg	Peer Median	Verdict
Asset Turnover		0.05Y avg ≈0.0	≈0.0	0.3	Weak
Revenue / Employee		≈$223.60	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise -20.5%

Next Report Nov 09, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 10, 2026	$-1.92	$-2.06	6.7%
March 31, 2026	May 11, 2026	$-1.10	$-2.41	54.4%
Dec. 31, 2025		$-7.50	$-2.28	-229.5%
Sept. 30, 2025		$-2.13	$-2.70	21.0%
June 30, 2025		$-2.89	$-3.65	20.9%
March 31, 2025		$-3.54	$-3.67	3.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 13

Metric	2025	2024	2023	2022	2021	2020
Revenue	$36.0K	$61.0K	$130.0K	$85M	$11M	$8M
R&D Expense	·	·	$183M	$159M	$139M	$182M
SG&A Expense	$45M	$52M	$67M	$117M	$89M	$47M
Operating Expenses	$269M	$359M	$247M	$272M	$225M	$220M
Operating Income	$-269M	$-359M	$-247M	$-187M	$-215M	$-212M
Other Non-op	$-18M	$5M	$2M	$2M	$-161.0K	$2M
Income Tax	$0	·	·	·	·	·
Net Income	$-274M	$-343M	$-235M	$-183M	$-250M	$-204M
EPS (Basic)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	$-15.69
EPS (Diluted)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	$-15.69
Shares (Basic)	17,093,000	13,074,000	12,549,000	247,080,000	135,918,000	13,258,000
Shares (Diluted)	17,093,000	13,074,000	12,549,000	247,080,000	135,918,000	13,258,000
EBITDA	$-258M	$-339M	$-227M	$-169M	$-201M	·

Balance Sheet 21

Metric	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$60M	$106M	$146M	$124M	$294M	$140M
Short-term Investments	$187M	$265M	$401M	$517M	$321M	$472M
Prepaid Expense	$14M	$9M	$8M	$11M	$11M	$5M
Current Assets	$261M	$380M	$555M	$651M	$626M	$618M
PP&E (Net)	$35M	$48M	$103M	$123M	$120M	$77M
PP&E (Gross)	$109M	$119M	$154M	$155M	$135M	$82M
Accum. Depreciation	$74M	$71M	$52M	$32M	$15M	$5M
Other Non-current Assets	$5M	$5M	$4M	$5M	$3M	$3M
Total Assets	$340M	$491M	$750M	$938M	$1.13B	$908M
Accounts Payable	$3M	$5M	$5M	$4M	$3M	$9M
Current Liabilities	$49M	$54M	$35M	$37M	$47M	$49M
Capital Leases	$42M	$51M	$57M	$63M	$67M	$51M
Other Non-current Liabilities	$517.0K	$3M	$4M	$4M	$5M	$532.0K
Total Liabilities	$92M	$108M	$95M	$104M	$198M	$190M
Common Stock	$2.0K	$1.0K	$25.0K	$25.0K	$24.0K	$2.0K
Paid-in Capital	$1.87B	$1.73B	$1.66B	$1.61B	$1.52B	$41M
Retained Earnings	$-1.62B	$-1.35B	$-1.00B	$-767M	$-584M	$-334M
AOCI	$242.0K	$291.0K	$-94.0K	$-8M	$-2M	$256.0K
Stockholders' Equity	$248M	$383M	$655M	$833M	$930M	$-293M
Liabilities + Equity	$340M	$491M	$750M	$938M	$1.13B	$908M
Shares Outstanding	21,251,000	14,744,000	12,698,000	12,479,000	242,738,000	15,570,000

Cash Flow 13

Metric	2025	2024	2023	2022	2021	2020
D&A	$12M	$20M	$20M	$18M	$14M	$4M
Stock-based Comp	$42M	$33M	$47M	$82M	$62M	$33M
Restructuring	·	·	$6M	·	·	·
Other Non-cash	$71M	$128M	$4M	$-86M	$48M	·
Operating Cash Flow	$-150M	$-162M	$-164M	$-170M	$-126M	$-161M
CapEx	$780.0K	$464.0K	$3M	$24M	$66M	$51M
Investing Cash Flow	$54M	$122M	$184M	$-12M	$-122M	$-274M
Stock Issued	$50M	$0	$0	·	·	·
Stock Repurchased	·	·	·	$0	$0	$12M
Net Stock Activity	$50M	·	·	$0	$0	·
Financing Cash Flow	$50M	$1M	$2M	$11M	$401M	$477M
Net Change in Cash	$-46M	$-39M	$22M	$-170M	$153M	$42M
Free Cash Flow	$-151M	$-163M	$-166M	$-194M	$-192M	·

Profitability 5

Metric	2025	2024	2023	2022	2021	2020
Operating Margin	-748344.4%	-588123.0%	-190006.1%	-220.9%	-2016.7%	·
Net Margin	-762355.6%	-562285.2%	-180486.1%	-216.2%	-2349.5%	·
EBITDA Margin	-716291.7%	-555941.0%	-174429.2%	-199.6%	-1888.8%	·
ROA	-66.1%	-55.3%	-27.8%	-17.7%	-24.6%	·
ROE	-100.3%	-75.1%	-34.7%	-22.1%	-26.1%	·

Liquidity & Solvency 2

Metric	Trend	2025	2024	2023	2022	2021	2020
Current Ratio		5.3	7.1	16.1	17.6	13.4	·
Quick Ratio		5.0	6.9	15.8	17.3	13.2	·

Efficiency 1

Metric	Trend	2025	2024	2023	2022	2021	2020
Asset Turnover		0.0	0.0	0.0	0.1	0.0	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020
Book Value / Share	$11.68	$1.30	$2.58	$3.34	$3.83	·
Revenue / Share	$0.00	$0.00	$0.00	$0.34	$78.36	·
Cash Flow / Share	$-8.78	$-0.62	$-0.65	$-0.69	$-928.86	·
Cash / Share	$2.83	$0.36	$0.57	$0.50	$1.21	·
EPS (TTM)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020
Revenue YoY	-41.0%	-53.1%	-99.9%	695.1%	37.3%	·
Revenue CAGR 3Y	-92.5%	-82.1%	-74.4%	·	·	·
Revenue CAGR 5Y	-65.8%	·	·	·	·	·

Valuation (TTM) 10

Metric	2025	2024	2023	2022	2021	2020
Revenue TTM	$36.0K	$61.0K	$130.0K	$85M	$11M	·
Net Income TTM	$-274M	$-343M	$-235M	$-183M	$-250M	·
Market Cap	$654M	$3.77B	$9.85B	$17.32B	$37.58B	·
P/E	-1.9	-0.5	-2.1	-93.8	-84.1	·
P/S	18169.6	61875.6	75796.7	204.5	3528.2	·
P/B	2.6	9.9	15.0	20.8	40.4	·
P / Tangible Book	2.6	9.9	15.0	20.8	40.4	·
P / Cash Flow	-4.4	-23.2	-60.2	-102.1	-297.6	·
P / FCF	-4.3	-23.2	-59.2	-89.4	-196.0	·
Earnings Yield	-52.2%	-204.9%	-48.2%	-1.1%	-1.2%	·

Income Statement 12

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue	$4.0K	$2.0K	$6.0K	$15.0K	$8.0K	$7.0K	$11.0K	$34.0K	$13.0K	$3.0K	$25.0K	$27.0K	$65.0K	$3.0K	$36M	$553.0K
R&D Expense	$40M	$37M	·	$28M	$35M	$43M	·	$40M	$40M	$43M	$44M	$47M	$45M	$42M	$44M	$36M
SG&A Expense	$10M	$10M	$11M	$11M	$10M	$14M	$15M	$12M	$12M	$13M	$16M	$19M	$19M	$26M	$30M	$34M
Operating Expenses	$47M	$44M	$128M	$37M	$47M	$57M	$201M	$51M	$52M	$56M	$59M	$66M	$63M	$66M	$73M	$69M
Operating Income	$-47M	$-44M	$-128M	$-37M	$-47M	$-57M	$-201M	$-51M	$-52M	$-56M	$-59M	$-66M	$-63M	$-66M	$-37M	$-69M
Other Non-op	$398.0K	$18M	$-16M	$-5M	$1M	$1M	$4M	$-43.0K	$-645.0K	$1M	$2M	$-326.0K	$1M	$-1M	$-14.0K	$35.0K
Net Income	$-45M	$-24M	$-141M	$-39M	$-43M	$-52M	$-192M	$-45M	$-46M	$-61M	$-51M	$-64M	$-67M	$-70M	$-36M	$-68M
EPS (Basic)	$-1.92	$-1.10	$-10.86	$-2.13	$-2.89	$-3.54	$-18.92	$-3.48	$-3.59	$-0.24	$-0.20	$-0.26	$-0.27	$-0.28	$-0.15	$-0.28
EPS (Diluted)	$-1.92	$-1.10	$-10.86	$-2.13	$-2.89	$-3.54	$-18.92	$-3.48	$-3.59	$-0.24	$-0.20	$-0.26	$-0.27	$-0.28	$-0.15	$-0.28
Shares (Basic)	23,364,000	21,876,000	·	18,268,000	14,793,000	14,755,000	·	12,815,000	12,770,000	254,252,000	251,318,000	250,204,000	249,591,000	248,320,000	246,312,000	244,178,000
Shares (Diluted)	23,364,000	21,876,000	·	18,268,000	14,793,000	14,755,000	·	12,815,000	12,770,000	254,252,000	251,318,000	250,204,000	249,591,000	248,320,000	246,312,000	244,178,000
EBITDA	$-47M	$-42M	·	$-37M	$-47M	$-54M	·	$-51M	·	$-51M	$-59M	$-66M	$-58M	$-66M	$-37M	$-64M

Balance Sheet 21

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$73M	$91M	$60M	$124M	$99M	$120M	$106M	$100M	$133M	$126M	$286M	$224M	$109M	$116M	$206M	$223M
Short-term Investments	$131M	$163M	$187M	$196M	$178M	$181M	$265M	$340M	$358M	$401M	$289M	$371M	$503M	$532M	$450M	$391M
Prepaid Expense	$9M	$13M	$14M	$9M	$5M	$8M	$9M	$9M	$9M	$8M	$11M	$11M	$12M	$12M	$11M	$12M
Current Assets	$214M	$267M	$261M	$328M	$282M	$309M	$380M	$450M	$500M	$534M	$587M	$606M	$624M	$660M	$667M	$626M
PP&E (Net)	$31M	$33M	$35M	$37M	$39M	$44M	$48M	$88M	$93M	$98M	$108M	$114M	$119M	$126M	$128M	$126M
PP&E (Gross)	·	·	$109M	·	·	·	$119M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$74M	·	·	·	$71M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$6M	$5M	$5M	$3M	$3M	$3M	$5M	$5M	$4M	$4M	$4M	$5M	$5M	$3M	$4M	$4M
Total Assets	$311M	$351M	$340M	$408M	$385M	$430M	$491M	$619M	$654M	$694M	$795M	$835M	$880M	$977M	$1.02B	$1.07B
Accounts Payable	$4M	$5M	$3M	$3M	$3M	$4M	$5M	$4M	$4M	$5M	$4M	$6M	$6M	$5M	$4M	$7M
Current Liabilities	$40M	$37M	$49M	$32M	$37M	$41M	$54M	$34M	$31M	$32M	$35M	$34M	$31M	$51M	$50M	$41M
Capital Leases	$37M	$39M	$42M	$44M	$47M	$49M	$51M	$51M	$53M	$55M	$59M	$60M	$62M	$65M	$66M	$67M
Other Non-current Liabilities	$537.0K	$527.0K	$517.0K	$3M	$3M	$3M	$3M	$4M	$3M	$4M	$4M	$4M	$4M	$4M	$4M	$4M
Total Liabilities	$77M	$77M	$92M	$79M	$87M	$93M	$108M	$89M	$88M	$91M	$97M	$98M	$97M	$157M	$154M	$191M
Common Stock	$2.0K	$2.0K	$2.0K	$2.0K	$1.0K	$30.0K	$1.0K	$26.0K	$26.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K
Paid-in Capital	$1.92B	$1.92B	$1.87B	$1.81B	$1.74B	$1.73B	$1.73B	$1.68B	$1.68B	$1.67B	$1.65B	$1.64B	$1.62B	$1.59B	$1.57B	$1.54B
Retained Earnings	$-1.69B	$-1.64B	$-1.62B	$-1.48B	$-1.44B	$-1.40B	$-1.35B	$-1.15B	$-1.11B	$-1.06B	$-949M	$-898M	$-834M	$-759M	$-689M	$-653M
AOCI	$-158.0K	$-9.0K	$242.0K	$201.0K	$57.0K	$158.0K	$291.0K	$760.0K	$-397.0K	$-404.0K	$-1M	$-2M	$-4M	$-10M	$-8M	$-7M
Stockholders' Equity	$234M	$274M	$248M	$329M	$299M	$337M	$383M	$531M	$567M	$603M	$698M	$737M	$784M	$820M	$868M	$881M
Liabilities + Equity	$311M	$351M	$340M	$408M	$385M	$430M	$491M	$619M	$654M	$694M	$795M	$835M	$880M	$977M	$1.02B	$1.07B
Shares Outstanding	23,397,000	23,328,000	21,251,000	19,294,000	14,831,000	295,284,000	14,744,000	256,564,000	255,948,000	254,927,000	251,869,000	251,027,000	249,609,000	249,240,000	247,110,000	245,423,000

Cash Flow 10

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
D&A	$2M	$2M	$2M	$3M	$3M	$3M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$4M	$4M
Stock-based Comp	$5M	$4M	$26M	$5M	$5M	$6M	$8M	$8M	$8M	$9M	$11M	$14M	$14M	$19M	$22M	$22M
Other Non-cash	·	$-21M	·	·	·	$-12M	·	·	·	$4M	·	·	$2M	·	·	$-6M
Operating Cash Flow	$-34M	$-39M	$-32M	$-29M	$-34M	$-55M	$-47M	$-35M	$-38M	$-42M	$-38M	$-39M	$-46M	$-37M	$-44M	$-48M
CapEx	$256.0K	$89.0K	$304.0K	$62.0K	$168.0K	$246.0K	$44.0K	$59.0K	$331.0K	$30.0K	$195.0K	$933.0K	$2M	$3M	$7M	$10M
Investing Cash Flow	$16M	$17M	$-31M	$3M	$13M	$69M	$54M	$2M	$45M	$22M	$100M	$153M	$32M	$-57M	$25M	$-26M
Stock Issued	·	·	$0	·	·	·	$0	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$522.0K	$52M	$222.0K	$50M	$183.0K	$1.0K	$437.0K	$0	$862.0K	$27.0K	$-143.0K	$1M	$-69.0K	$5M	$2M	$3M
Net Change in Cash	$-18M	$31M	$-63M	$25M	$-22M	$15M	$7M	$-33M	$8M	$-20M	$62M	$115M	$-14M	$-89M	$-17M	$-71M
Free Cash Flow	·	$-39M	·	·	·	$-55M	·	·	·	$-42M	·	·	$-48M	·	·	$-58M

Profitability 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Operating Margin	-1183425.0%	-2213050.0%	·	-248353.3%	-589250.0%	-819528.6%	·	-148544.1%	·	-1852500.0%	-236156.0%	-244092.6%	-96240.0%	-2214566.7%	-104.2%	-12400.7%
Net Margin	-1118875.0%	-1207650.0%	·	-258973.3%	-533550.0%	-745642.9%	·	-131126.5%	·	-2022233.3%	-203412.0%	-236629.6%	-103013.9%	-2341800.0%	-101.6%	-12322.6%
EBITDA Margin	-1183425.0%	-2096450.0%	·	-248353.3%	-589250.0%	-770371.4%	·	-148544.1%	·	-1685033.3%	-236156.0%	-244092.6%	-88506.2%	-2214566.7%	-104.2%	-11643.6%
ROA	-12.8%	-6.2%	·	-7.6%	-8.2%	-9.3%	·	-6.3%	·	-7.7%	-5.7%	-6.9%	-6.9%	-6.5%	-3.2%	-12.7%
ROE	-16.8%	-7.9%	·	-9.0%	-9.9%	-11.1%	·	-7.3%	·	-8.8%	-6.7%	-8.0%	-8.0%	-7.8%	-3.8%	-15.5%

Liquidity & Solvency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio		5.4	7.2	·	10.3	7.6	7.5	·	13.4	·	16.5	16.7	17.6	20.3	12.9	13.3	15.2
Quick Ratio		5.1	6.9	·	10.0	7.5	7.3	·	13.1	·	16.3	16.4	17.3	19.9	12.7	13.0	15.0

Efficiency 1

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	·	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$9.99	$11.73	·	$17.06	$20.16	$1.14	·	$2.07	·	$2.37	$2.77	$2.94	$3.14	$3.29	$3.51	$3.59
Revenue / Share	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	·	$0.00	$0.00	$0.00	$0.00	$0.00	$0.15	$0.00
Cash Flow / Share	·	$-1.76	·	·	·	$-0.19	·	·	·	$-0.17	·	·	$-0.19	·	·	$-0.20
Cash / Share	$3.12	$3.89	·	$6.40	$6.66	$0.41	·	$0.39	·	$0.49	$1.14	$0.89	$0.44	$0.47	$0.83	$0.91
EPS (TTM)	$-16.01	$-16.98	·	$-27.48	$-28.83	$-29.53	·	$-25.28	$-22.00	$-18.67	$-0.76	$-0.84	$-0.73	$2.31	$2.39	$1.07

Valuation (TTM) 9

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$27.0K	$31.0K	·	$41.0K	$60.0K	$65.0K	·	$63.0K	$54.0K	$68.0K	$49M	$48M	$84M	$39M	$42M	$9M
Net Income TTM	$-248M	$-246M	·	$-326M	$-331M	$-335M	·	$-204M	$-210M	$-228M	$-190M	$-210M	$-182M	$-258M	$-237M	$-263M
Market Cap	$329M	$468M	·	$313M	$131M	$3.18B	·	$7.08B	·	$11.37B	$7.40B	$15.97B	$11.78B	$36.54B	$32.22B	$24.79B
P/E	-0.9	-1.2	·	-0.6	-0.3	-0.4	·	-1.1	-1.3	-2.4	-38.7	-75.7	-64.7	63.5	54.6	94.4
P/S	12175.1	15095.5	·	7642.3	2185.1	48880.9	·	112399.5	·	167202.1	152.7	329.3	139.9	934.0	769.6	2830.3
P/B	1.4	1.7	·	1.0	0.4	9.4	·	13.3	·	18.9	10.6	21.7	15.0	44.6	37.1	28.1
P / Tangible Book	1.4	1.7	·	1.0	0.4	9.4	·	13.3	13.1	18.9	10.6	21.7	15.0	44.6	37.1	28.1
P / Cash Flow	·	-12.2	·	·	·	-58.0	·	·	·	-270.6	·	·	-254.9	·	·	-518.0
Earnings Yield	-113.9%	-84.7%	·	-169.2%	-326.1%	-274.4%	·	-91.6%	-75.9%	-41.9%	-2.6%	-1.3%	-1.6%	1.6%	1.8%	1.1%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$36.0K	$61.0K	$130.0K	$85M	$11M
Operating Margin %	-748344.4%	-588123.0%	-190006.1%	-220.9%	-2016.7%
Net Income	$-274M	$-343M	$-235M	$-183M	$-250M
Diluted EPS	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Current Ratio	5.3	7.1	16.1	17.6	13.4
Quick Ratio	5.0	6.9	15.8	17.3	13.2

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-151M	$-163M	$-166M	$-194M	$-192M

Institutional owners (13F) 95 filers · $240.0M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 95

Value held $240.0M

New positions 26

Exited positions 9

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
26 (+6 vs prior Q)	9 (+3 vs prior Q)	29 (+4 vs prior Q)	19 (+11 vs prior Q)	+67K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
ARCH Venture Management, LLC	$45,525,211	3,247,162	18.97%	Shares
MWG Caph Ltd	$31,029,810	1,008,116	12.93%	Shares
VANGUARD GROUP INC	$25,437,516	826,430	10.60%	Shares
GSK plc	$21,252,859	1,512,659	8.86%	Shares
MWG Management Ltd.	$16,371,804	1,008,116	6.82%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$11,054,175	786,774	4.61%	Shares
Orland Properties Ltd	$10,603,507	754,698	4.42%	Shares
BlackRock, Inc.	$10,177,005	724,342	4.24%	Shares
Almitas Capital LLC	$8,168,768	581,407	3.40%	Shares
Foresite Capital Management V, LLC	$6,693,223	476,386	2.79%	Shares
MILLENNIUM MANAGEMENT LLC	$5,162,996	367,473	2.15%	Shares
Opaleye Management Inc.	$4,833,551	344,025	2.01%	Shares
venBio Partners LLC	$4,744,643	337,697	1.98%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$4,365,887	310,636	1.82%	Shares
Alphabet Inc.	$4,120,247	293,256	1.72%	Shares
STATE STREET CORP	$2,603,774	185,322	1.08%	Shares
HSG Holding Ltd	$2,139,801	152,299	0.89%	Shares
RENAISSANCE TECHNOLOGIES LLC	$1,829,169	130,190	0.76%	Shares
NORTHERN TRUST CORP	$1,664,925	118,500	0.69%	Shares
Qube Research & Technologies Ltd	$1,552,961	110,531	0.65%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1,511,359	107,570	0.63%	Shares
MARSHALL WACE, LLP	$1,493,516	106,300	0.62%	Shares
Velan Capital Investment Management LP	$1,475,250	105,000	0.61%	Shares
VANGUARD FIDUCIARY TRUST CO	$1,307,985	93,095	0.54%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$1,291,069	91,891	0.54%	Shares
MIC Capital Management UK LLP	$1,222,743	87,028	0.51%	Shares
GOLDMAN SACHS GROUP INC	$1,219,245	86,779	0.51%	Shares
DIMENSIONAL FUND ADVISORS LP	$957,066	68,315	0.40%	Shares
TWO SIGMA INVESTMENTS, LP	$743,624	52,927	0.31%	Shares
JANE STREET GROUP, LLC	$646,455	46,011	0.27%	Shares
Squarepoint Ops LLC	$594,624	42,322	0.25%	Shares
Ikarian Capital, LLC	$577,188	41,081	0.24%	Shares
MORGAN STANLEY	$520,553	37,050	0.22%	Shares
CANADA PENSION PLAN INVESTMENT BOARD	$413,225	29,411	0.17%	Shares
Point72 Asset Management, L.P.	$366,424	26,080	0.15%	Shares
UBS Group AG	$365,048	25,982	0.15%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$363,895	25,900	0.15%	Call option
Bank of New York Mellon Corp	$346,656	24,673	0.14%	Shares
AMERICAN CENTURY COMPANIES INC	$344,787	24,540	0.14%	Shares
Jump Financial, LLC	$308,482	21,956	0.13%	Shares
Clearstead Advisors, LLC	$280,410	19,958	0.12%	Shares
EntryPoint Capital, LLC	$272,710	19,410	0.11%	Shares
CITADEL ADVISORS LLC	$262,665	18,695	0.11%	Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$252,900	18,000	0.11%	Shares
CITADEL ADVISORS LLC	$251,495	17,900	0.10%	Put option
Susquehanna Portfolio Strategies, LLC	$251,144	17,875	0.10%	Shares
CITADEL ADVISORS LLC	$238,850	17,000	0.10%	Call option
Allspring Global Investments Holdings, LLC	$226,837	16,145	0.09%	Shares
RHUMBLINE ADVISERS	$217,234	15,462	0.09%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$199,510	14,200	0.08%	Put option

Show all 95 institutional owners →

Company insiders 25 insiders · 14 officers · 11 directors

19

Insider	Role	Last activity	Shares owned	Sells 12m	Net 12m
Lynn Seely	President and CEO	Aug. 21, 2026 S	63,899	6	$-353,079
Elizabeth Homans	Chief Executive Officer	March 16, 2022 A	·	0	$0
Charles W. Newton	Chief Financial Officer	Aug. 21, 2025 S	15,306	0	$0
Stephen J. Hill	Chief Operating Officer	Aug. 21, 2026 S	16,816	6	$-51,290
Jarrad Mattieu Aguirre	Chief Medical Officer	Sept. 10, 2026 A	·	0	$0
David Shook	Chief Medical Officer	Sept. 10, 2026 S	20,423	2	$-31,339
Gary K. Lee	Chief Scientific Officer	Aug. 21, 2026 S	16,220	6	$-71,695
Veronica Sanchez Bulis	VP, Corporate Controller	Aug. 10, 2026 S	14,799	6	$-96,909
Smital Shah	Chief Fin. and Bus. Officer	March 9, 2026 A	·	0	$0
Mark A Meltz	General Counsel	Feb. 10, 2026 A	·	0	$0
Matthew Lang	Chief Business Officer	Feb. 10, 2025 A	162,500	0	$0
Tina M. Albertson	Chief Medical Officer	Feb. 24, 2023 A	·	0	$0
Rahsaan Thompson	Chief Legal Officer	Feb. 24, 2023 A	·	0	$0
Heather D Turner	Chief General Counsel	March 16, 2022 A	·	0	$0
Mark Bachleda	Director	June 10, 2026 A	·	0	$0
Elizabeth G Nabel	Director	June 10, 2026 A	·	0	$0
Richard Klausner	Director	June 10, 2026 A	843,365	0	$0
Sumant Ramachandra	Director	June 10, 2026 A	200,000	0	$0
Cathy Friedman	Director	June 10, 2026 A	236,370	0	$0
Otis W Brawley	Director	June 10, 2026 A	35,640	0	$0
William Jl Rieflin	Director	June 10, 2026 A	·	0	$0
Hans Edgar Bishop	Director	June 14, 2024 A	4,685,614	0	$0
Robert Nelsen	Director	June 14, 2024 A	18,206,358	0	$0
Innovative Cellular Therapeutics Holdings Ltd	10% owner	July 27, 2026 J	2,818,980	2	$-274
GSK plc	·	June 21, 2021 C	30,253,189	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 16 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
IWC · iShares Trust	0.03%	32,319 SH	Sept. 11, 2026	Daily
IBBQ · Invesco Exchange-Traded Fund Trust …	0.02%	1,674 SH	Oct. 1, 2026	Daily
VTWV · VANGUARD SCOTTSDALE FUNDS	0.01%	8,183 SH	Aug. 19, 2026	Daily
IBB · iShares Trust	0.01%	57,662 SH	Sept. 11, 2026	Daily
RSSL · Global X Funds	0.00%	4,474 NS	July 31, 2026	N-PORT
IWM · iShares Trust	0.00%	222,823 SH	Sept. 11, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.00%	9,045 SH	Oct. 1, 2026	Daily
DCOR · Dimensional ETF Trust	0.00%	1,961 NS	July 31, 2026	N-PORT
DFAS · Dimensional ETF Trust	0.00%	1,736 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.00%	163,755 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.00%	604,461 SH	Aug. 19, 2026	Daily
VTWO · VANGUARD SCOTTSDALE FUNDS	0.00%	54,398 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	1,151 SH	Aug. 19, 2026	Daily
DFAC · Dimensional ETF Trust	0.00%	409 NS	July 31, 2026	N-PORT
VHT · VANGUARD WORLD FUND	0.00%	28,159 SH	Aug. 19, 2026	Daily
IWN · iShares Trust	·	89,130 SH	Sept. 11, 2026	Daily

LYEL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 14 analysts BUY

Median target $41.50 +348.2%

4 28.6% Strong Buy

8 57.1% Buy

1 7.1% Hold

1 7.1% Sell

0 0.0% Strong Sell

12-Month Price Target

8 analysts · 2026-10-02

Mean target $37.88 +309.0%

← Below all targets Current price $9.26

Low$12.00 Mean$37.88 High$49.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
LYEL	$654M	-1.9	-41.0%	-762355.6%	-100.3%	·
CAMP	$318M	-2.3	436.5%	-2298.5%	-183.4%	·
EVMN	$540M	-1.5	85.7%	-529.8%	-401.2%	·
AKBA	$427M	-80.5	47.5%	-2.3%	-17.3%	·
IVVD	$697M	-8.2	110.5%	-98.2%	-36.9%	·
MGNX	$102M	-1.4	-0.31%	-49.9%	-87.0%	·
KROS	$398M	8.9	·	35.7%	17.2%	·
RNAC	$188M	-1.4	-92.8%	-4658.6%	202.4%	·
SION	$1.84B	-21.9	·	·	-23.4%	·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

LYEL Lyell Immunopharma, Inc. - Common Stock